West-Ward Recalls Doxercalciferol Capsules Due to Illegible Print
West-Ward Columbus, Inc. is recalling Doxercalciferol Capsules 0.5mcg because capsules were found with illegible print during an internal inspection.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, and the hazard is limited to illegible print (a documentation/packaging issue) with no reported health risks.
Plain-English summary
West-Ward Columbus, Inc. is recalling 100 bottles of Doxercalciferol Capsules 0.5mcg, NDC 0054-0338-19. The product is a prescription-only medication manufactured by Cipla Limited in India for West-Ward Pharmaceuticals, Corp. The recall involves Lot KB60707 with an expiration date of 10/31/2018.
The recall was initiated because an internal inspection found capsules with illegible print, which failed tablet/capsule specifications. The recalled product was distributed to Ohio. There are no Canada, Mexico, or government accounts associated with this recall.
Consumers should stop using the product and contact their healthcare provider or pharmacist for guidance on disposal or replacement. The FDA has classified this recall as Class III, indicating that use of the product is not likely to cause adverse health consequences.
The recalled product
- Product
- Doxercalciferol Capsules 0.5mcg, 50 count bottles, Rx, only, Manufactured by Cipla Limited Kurkumbh, Maharashtra, India, Manufactured for West-Ward, Pharmaceuticals, Corp., Eatontown, NJ -- NDC 0054-0338-19
- Manufacturer
- West-Ward Columbus, Inc.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 100
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot KB60707
- 10/31/2018
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · West-Ward Columbus, Inc.
See all →- ModerateMethadone Hydrochloride Tablets recalled for illegible product identification
FDA (Drugs) · 2025-01-15
- LowMethotrexate Sodium tablets recalled due to illegible markings and unsmooth surface
FDA (Drugs) · 2023-11-01
- LowWest-Ward Recalls Leucovorin Calcium Tablets With Incorrect Identification Code
FDA (Drugs) · 2020-08-19
- ModerateWest-Ward Recalls Doxycycline Hyclate Tablets Due to Dissolution Failure
FDA (Drugs) · 2020-06-03
- ModerateWest-Ward Recalls Ethacrynic Acid Tablets for Impurity Failures
FDA (Drugs) · 2020-05-27
Similar recalls
- SevereWest-Ward Recalls Subpotent Ethambutol Hydrochloride Tablets
FDA (Drugs) · 2013-04-10
- ModerateWest-Ward Recalls Doxycycline Hyclate Tablets for Dissolution Failures
FDA (Drugs) · 2018-08-08
- ModerateWest-Ward Recalls Doxycycline Hyclate Tablets for Failed Dissolution Specifications
FDA (Drugs) · 2018-08-08
- ModerateWest-Ward Recalls Ethacrynic Acid Tablets for Impurity Failures
FDA (Drugs) · 2020-05-27
- ModerateWest-Ward Recalls Doxycycline Hyclate Tablets Due to Dissolution Failure
FDA (Drugs) · 2020-06-03
- ModerateExela Pharma Recalls Diclofenac and Misoprostol Tablets Due to Labeling Error
FDA (Drugs) · 2018-05-30